title: The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera.
authors.forename: Holger
authors.initials: H
authors.lastname: Cario
authors.forename: Philipp S
authors.initials: PS
authors.lastname: Goerttler
authors.forename: Cordula
authors.initials: C
authors.lastname: Steimle
authors.forename: Ross L
authors.initials: RL
authors.lastname: Levine
authors.forename: Heike L
authors.initials: HL
authors.lastname: Pahl
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004252:DNA Mutational Analysis; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D053614:Janus Kinase 2; D008297:Male; D008875:Middle Aged; D008957:Models, Genetic; D009196:Myeloproliferative Disorders / Q000235:genetics; D010375:Pedigree; D011087:Polycythemia Vera / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2